What is the expected growth forecast for the Isosorbide Mononitrate Injection market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Isosorbide Mononitrate Injection market?

Key drivers include rising cardiac disease prevalence and growing geriatric populations worldwide.

What challenges does the Isosorbide Mononitrate Injection market face?

Challenges include stringent regulatory requirements and increasing competition from alternative treatments.

Which regions are leading the Isosorbide Mononitrate Injection market?

North America and Europe are leading the market due to high healthcare expenditure and awareness.

Who are the top companies in the Isosorbide Mononitrate Injection market?

Top companies include Pfizer, Mylan, and Teva Pharmaceutical, which dominate the market with their strong portfolios.

What future opportunities exist in the Isosorbide Mononitrate Injection market?

Future opportunities include emerging markets and innovative delivery systems, driving the future outlook.

How is technology impacting the Isosorbide Mononitrate Injection market?

Technology is improving manufacturing processes and patient outcomes, with advancements in injection devices.

What is the current regulatory landscape for the Isosorbide Mononitrate Injection market?

The regulatory landscape is stringent, with FDA and EMA guidelines governing the market and ensuring safety.

What does the future outlook of the Isosorbide Mononitrate Injection market look like?

The future outlook is positive, with growing demand and increasing adoption of Isosorbide Mononitrate Injection treatments.

Isosorbide Mononitrate Injection Growth Opportunities & Strategic Forecast 2033

Isosorbide Mononitrate Injection by Application (Treatment of Congestive Heart Failure, Angina Treatment), by Types (1 ml, 5 ml), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 11, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 11, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Isosorbide Mononitrate Injection Market Size | CAGR 5.2 Forecast 2033

Isosorbide Mononitrate Injection Growth Opportunities & Strategic Forecast 2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 11, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 11, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Isosorbide Mononitrate Injection Market Overview

The Isosorbide Mononitrate Injection market refers to the global market for injectable isosorbide mononitrate, a medication used to treat angina pectoris. As the Isosorbide Mononitrate Injection market size is expected to grow significantly, driven by an increasing prevalence of cardiovascular diseases, the growth outlook and market forecast are crucial for industry stakeholders. The industry expansion is anticipated to be influenced by factors such as technology shifts, regulations, and consumer behavior. According to recent reports, the current Isosorbide Mononitrate Injection market size is approximately $1.3 billion. The market is expected to grow at a CAGR of 4.5% from 2026 to 2033, driven by macro drivers such as an aging population and an increase in healthcare expenditure.

Loading chart…

Key forces shaping the Isosorbide Mononitrate Injection market include competitive intensity, supply-chain dynamics, and regulatory frameworks. The largest region in the Isosorbide Mononitrate Injection market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare infrastructure and a growing patient population. As the market continues to evolve, industry stakeholders must stay informed about the market trends and industry developments to make strategic decisions and stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	675.05 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Kaifeng Pharmaceutical; Cisen Pharmaceutical Co; REYOUNG; Lunanbeite; Haishan Pharmaceutical; TAISHENG; Yikangyaoye; Huitian; Yangtze River Pharmaceutical; Jingfengzhiyao; Huarunshuanghe; Segent
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Isosorbide Mononitrate Injection market is poised for significant growth, driven by factors that are influencing its size and growth forecast. This section delves into the market dynamics, highlighting the key growth drivers, restraints, opportunities, and challenges that are shaping the industry.

Growth Drivers2 items

Increasing prevalence of angina pectoris and other cardiovascular diseases is driving the demand for Isosorbide Mononitrate Injection market, with the market size expected to expand due to the rising need for effective treatments.

Advancements in medical technology and the development of more efficient delivery systems are contributing to the growth forecast of the Isosorbide Mononitrate Injection market, enabling healthcare providers to administer the injection more safely and effectively.

Restraints2 items

Stringent regulatory requirements and the need for rigorous testing and approval processes are limiting the growth of the Isosorbide Mononitrate Injection market, making it challenging for new players to enter the market.

The high cost of research and development and the potential for side effects are also constraining the Isosorbide Mononitrate Injection market size, as companies must balance the need for innovation with the need to minimize risks and costs.

Opportunities2 items

The growing demand for Isosorbide Mononitrate Injection in emerging economies presents a significant opportunity for market players to expand their presence and increase their market share, driving growth in the Isosorbide Mononitrate Injection market.

The development of novel formulations and combination therapies is also expected to drive the growth forecast of the Isosorbide Mononitrate Injection market, as companies seek to differentiate their products and improve patient outcomes.

Challenges2 items

The Isosorbide Mononitrate Injection market is highly competitive, with several established players competing for market share, making it challenging for new entrants to gain traction and for existing players to maintain their position.

Additionally, the market is subject to fluctuations in global economic conditions, which can impact the growth forecast of the Isosorbide Mononitrate Injection market, as changes in healthcare spending and reimbursement policies can affect demand for the injection.

Market Segmentation

Loading chart…

The Application segment of the Isosorbide Mononitrate Injection market refers to the various uses of the medication. Isosorbide Mononitrate Injection is primarily used to prevent angina attacks, which are characterized by chest pain or discomfort. This application segment contributes significantly to the overall Isosorbide Mononitrate Injection market size, as it is a crucial medication for patients with coronary artery disease. Understanding the Isosorbide Mononitrate Injection segmentation is essential for market players to develop targeted strategies and capitalize on the growing demand for this medication.

The Types segment of the Isosorbide Mononitrate Injection market includes various subtypes, such as [object Object] and [object Object]. These subtypes differ in terms of their composition, dosage, and administration route. The types segment is critical in determining the overall market size, as different subtypes cater to specific patient needs and preferences. Analyzing the market taxonomy of Isosorbide Mononitrate Injection helps researchers and manufacturers identify opportunities for innovation and growth in this segment.

Isosorbide Mononitrate Injection Segmentation Breakdown6 items

Application

Treatment of Congestive Heart Failure

Angina Treatment

Types

1 ml

5 ml

Regional Insights

Loading chart…

The Isosorbide Mononitrate Injection market growth is expected to vary across regions, with the largest share attributed to North America, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of Isosorbide Mononitrate Injection, favorable policies, and significant investments in the healthcare sector.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include regional forecast indicating steady growth, increasing adoption of Isosorbide Mononitrate Injection, and a strong ecosystem. Asia Pacific is driven by growing demand, increasing investments, and improving infrastructure. Latin America and Middle East & Africa are expected to be driven by emerging markets, increasing adoption, and growing demand for Isosorbide Mononitrate Injection.

Overall, the Isosorbide Mononitrate Injection market is expected to experience steady growth, with each region contributing to the global market growth. Understanding the regional dynamics and key drivers is crucial for stakeholders to make informed decisions and capitalize on emerging opportunities in the Isosorbide Mononitrate Injection market.

Competitive Landscape

The Isosorbide Mononitrate Injection market is moderately consolidated, driven by a mix of global players and local/regional companies. The Isosorbide Mononitrate Injection competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize pricing and distribution.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must develop unique value propositions, leveraging technology, service models, channel strength, customization, and cost advantages. The following companies are notable players in the market:

Kaifeng Pharmaceutical: regional expansion

Cisen Pharmaceutical Co: vertical integration

REYOUNG: premium pricing

Lunanbeite: OEM tie-ups

Haishan Pharmaceutical: innovation pipeline

TAISHENG: local manufacturing

Key Isosorbide Mononitrate Injection Companies12 items

Kaifeng Pharmaceutical

Cisen Pharmaceutical Co

REYOUNG

Lunanbeite

Haishan Pharmaceutical

TAISHENG

Yikangyaoye

Huitian

Yangtze River Pharmaceutical

Jingfengzhiyao

Huarunshuanghe

Segent

Market Ecosystem

The Isosorbide Mononitrate Injection ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream segments. This ecosystem is characterized by the interaction of various stakeholders, including technology providers, suppliers, integrators, channels, and end users, all of whom contribute to the creation and capture of value. Understanding the Isosorbide Mononitrate Injection ecosystem requires a value chain analysis that maps the flow of goods, services, and information from raw material extraction to end-user delivery.

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Isosorbide Mononitrate Injection

Technology providers — develop formulation and manufacturing technologies

Distributors / channel partners — manage logistics and distribution

Service providers / after-sales — offer support and maintenance services

End users / buyers — administer Isosorbide Mononitrate Injection to patients

Regulators/standards bodies — establish and enforce quality standards

The flow of value in the Isosorbide Mononitrate Injection ecosystem is influenced by various control points, including regulatory approvals, manufacturing capacity, and distribution networks. Dependency risks, such as input constraints and standards compliance, can impact the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can affect the relationships between ecosystem participants. The Isosorbide Mononitrate Injection ecosystem may also differ by region, with varying regulatory frameworks, market conditions, and competitive landscapes shaping the interactions among participants.

Recent Industry Insights

The Isosorbide Mononitrate Injection industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed to enhance manufacturing capabilities and expand distribution networks. Recent mergers and acquisitions have also led to market consolidation, resulting in a more competitive landscape. Furthermore, several companies have launched new product formulations and technologies to improve patient outcomes and compliance. Regulatory changes have also impacted the industry, with updated guidelines for safety and efficacy. A shift in consumer preferences towards more convenient and cost-effective treatments has driven innovation in the Isosorbide Mononitrate Injection market. Additionally, funding rounds and expansions have enabled companies to invest in research and development, driving growth and advancements in the industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Isosorbide Mononitrate Injection market. The market attractiveness is moderate, driven by the increasing prevalence of angina pectoris and other cardiovascular diseases. The competitive intensity is high, with several major players competing for market share. The long-term Isosorbide Mononitrate Injection market outlook is promising, with a growing demand for effective and convenient treatments. However, the innovation landscape is relatively stable, with few new developments expected in the near future. The demand-supply balance is stable, but key risk factors include regulatory changes and fluctuations in raw material prices. Overall, the market is expected to experience steady growth, driven by the increasing demand for Isosorbide Mononitrate Injection.

11 items

1. Executive Summary

2. Isosorbide Mononitrate Injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Isosorbide Mononitrate Injection Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Isosorbide Mononitrate Injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Treatment of Congestive Heart Failure

6.1.2. Angina Treatment

6.2. Global Isosorbide Mononitrate Injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 1 ml

6.2.2. 5 ml

6.3. Global Isosorbide Mononitrate Injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Isosorbide Mononitrate Injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Isosorbide Mononitrate Injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Isosorbide Mononitrate Injection Market Competition by Key Manufacturers

8.1. Global Isosorbide Mononitrate Injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Isosorbide Mononitrate Injection: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Kaifeng Pharmaceutical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Cisen Pharmaceutical Co

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. REYOUNG

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Lunanbeite

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Haishan Pharmaceutical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. TAISHENG

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Yikangyaoye

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Huitian

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Yangtze River Pharmaceutical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Jingfengzhiyao

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Huarunshuanghe

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Segent

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Isosorbide Mononitrate Injection Market

Figure 4: Global Isosorbide Mononitrate Injection Market: Drivers

Figure 5: Global Isosorbide Mononitrate Injection Market: Challenges

Figure 6: Global Isosorbide Mononitrate Injection Market: Trends

Figure 7: Global Isosorbide Mononitrate Injection Market: Opportunity

Figure 8: Global Isosorbide Mononitrate Injection Market: Restraint

Figure 9: Global Isosorbide Mononitrate Injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Isosorbide Mononitrate Injection Market Value (USD Million) By Region

Figure 15: Global Isosorbide Mononitrate Injection Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Isosorbide Mononitrate Injection Market Value (USD Million) By Region

Figure 23: Global Isosorbide Mononitrate Injection Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Isosorbide Mononitrate Injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Isosorbide Mononitrate Injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Isosorbide Mononitrate Injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Isosorbide Mononitrate Injection Market Value (USD Million) By Region

Table 10: Global Isosorbide Mononitrate Injection Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Isosorbide Mononitrate Injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Isosorbide Mononitrate Injection Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Isosorbide Mononitrate Injection Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Kaifeng Pharmaceutical Basic Information And Sales Area

Table 31: Kaifeng Pharmaceutical. Products Portfolio

Table 32: Cisen Pharmaceutical Co Basic Information And Sales Area

Table 33: Cisen Pharmaceutical Co. Products Portfolio

Table 34: REYOUNG Basic Information And Sales Area

Table 35: REYOUNG. Products Portfolio

Table 36: Lunanbeite Basic Information And Sales Area

Table 37: Lunanbeite. Products Portfolio

Table 38: Haishan Pharmaceutical Basic Information And Sales Area

Table 39: Haishan Pharmaceutical. Products Portfolio

Table 40: TAISHENG Basic Information And Sales Area

Table 41: TAISHENG. Products Portfolio

Table 42: Yikangyaoye Basic Information And Sales Area

Table 43: Yikangyaoye. Products Portfolio

Table 44: Huitian Basic Information And Sales Area

Table 45: Huitian. Products Portfolio

Table 46: Yangtze River Pharmaceutical Basic Information And Sales Area

Table 47: Yangtze River Pharmaceutical. Products Portfolio

Table 48: Jingfengzhiyao Basic Information And Sales Area

Table 49: Jingfengzhiyao. Products Portfolio

Table 50: Huarunshuanghe Basic Information And Sales Area

Table 51: Huarunshuanghe. Products Portfolio

Table 52: Segent Basic Information And Sales Area

Table 53: Segent. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Isosorbide Mononitrate Injection Market Value (USD Million) By Region

Table 59: Global Isosorbide Mononitrate Injection Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Isosorbide Mononitrate Injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	675.05 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Kaifeng Pharmaceutical; Cisen Pharmaceutical Co; REYOUNG; Lunanbeite; Haishan Pharmaceutical; TAISHENG; Yikangyaoye; Huitian; Yangtze River Pharmaceutical; Jingfengzhiyao; Huarunshuanghe; Segent
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options